Search

Pfizer's CEO is stepping down after 8 years - meet the man who will be replacing him

PFIZER'S CEO IS STEPPING DOWN AFTER 8 YEARS - MEET THE MAN WHO WILL BE REPLACING HIM

Pfizer CEO Ian Read is stepping down at the end of 2018, ending his eight-year tenure at the head of the pharma giant. He'll be replaced...

 
 
 
Pfizer's long-serving CEO Ian Read is standing down and being replaced by his chief operating officer

PFIZER'S LONG-SERVING CEO IAN READ IS STANDING DOWN AND BEING REPLACED BY HIS CHIEF OPERATING OFFICER

Pfizer announces that CEO Ian Read will stand down from the start of 2019. He will be replaced by Dr. Albert Bourla, who is currently...

SENIOR ASSOCIATE SCIENTIST , ENZYMOLOGY - PFIZER INC. - LA JOLLA, CA

The candidate will be responsible for testing compounds in biochemical assays, data analysis, and proper database publication of data...From...

 
 
 
Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away

BIO ROUNDUP: A GENE EDITING 1ST, CHINA RISES, SCHENKEIN STEPS AWAY

If you're still recovering from a Labor Day hangover or busy searching for the identity of the anonymous writer of the anti-Trump op-ed...

 
 
 
Bubble gum-flavored drinkable Advil recalled over confusing labels 

BUBBLE GUM-FLAVORED DRINKABLE ADVIL RECALLED OVER CONFUSING LABELS 

Pfizer has issued a voluntary recall across the US after receiving complaints that the dosing instructions use milliliters and the...

Bio Roundup: EpiPen Shortage, Bluebird's Bet, Biotech IPOs & More

BIO ROUNDUP: EPIPEN SHORTAGE, BLUEBIRD'S BET, BIOTECH IPOS & MORE

It's back-to-school season and that means it's time to load up on school supplies. For many students and schools, one crucial item...

 
 
 
Exact Sciences Shares Rise After Company Unveils Pfizer Partnership

EXACT SCIENCES SHARES RISE AFTER COMPANY UNVEILS PFIZER PARTNERSHIP

Exact Sciences has recently been ramping up its efforts to market Cologuard, the company's flagship diagnostic test that screens patients...

Pain Drug Race Continues as Regeneron Posts Early Phase 3 Results

PAIN DRUG RACE CONTINUES AS REGENERON POSTS EARLY PHASE 3 RESULTS

A new class of pain drugs that might offer an alternative to addictive opioids-if they're safe enough to use chronically-is inching...

 
 
 
Elanco's IPO Would Free Eli Lilly to Focus on Pharmaceuticals

ELANCO'S IPO WOULD FREE ELI LILLY TO FOCUS ON PHARMACEUTICALS

Elanco, the animal health business of Eli Lilly, has filed for an IPO, setting in motion the process of splitting from its parent company...

Bio Roundup: Alnylam's Moment, Read on Rebates, Skinny Plans & More

BIO ROUNDUP: ALNYLAM'S MOMENT, READ ON REBATES, SKINNY PLANS & MORE

Millions of people might be on vacation as we hit the dog days, but drug makers and politicians aren't taking a break from the gamesmanship...

 
 
 
Profit surges at Pfizer in 2Q on lower taxes, drug sales

PROFIT SURGES AT PFIZER IN 2Q ON LOWER TAXES, DRUG SALES

Pfizer's second-quarter profit surged 26 percent, thanks to a 4 percent increase in medicine sales, higher income from partnerships...

SENIOR PRINCIPAL SCIENTIST, STRATEGIC ALLIANCES - PFIZER INC. - LA JOLLA, CA

Depending on the nature of the partnership, the Senior Principal Scientist will independently build, develop, and manage all or parts...

 
 
 
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More

BIO ROUNDUP: DRUG PRICES, CRISPR CAVEATS, RUBIUS IPO POP & MORE

After nearly two years of all smoke, no fire around President Trump's promise to curtail drug prices, there's finally some glimmer...

 
 
 
Pfizer is holding off on price increases to some of its drugs after being singled out by Trump

PFIZER IS HOLDING OFF ON PRICE INCREASES TO SOME OF ITS DRUGS AFTER BEING SINGLED OUT BY TRUMP

President Donald Trump singled out pharma giant Pfizer on Monday in a tweet about drug pricing. Pfizer had increased the price of 100...